Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat.
Action Potentials
/ drug effects
Animals
Excitatory Amino Acid Antagonists
/ pharmacology
GABAergic Neurons
/ drug effects
Interneurons
/ drug effects
Intralaminar Thalamic Nuclei
/ cytology
Ketamine
/ pharmacology
Mediodorsal Thalamic Nucleus
/ cytology
Neurons
/ drug effects
Phencyclidine
/ pharmacology
Prefrontal Cortex
/ cytology
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate
/ antagonists & inhibitors
Thalamus
Wakefulness
Ketamine
NMDA receptor antagonists
Neuronal oscillations
Phencyclidine
Single unit recordings
Thalamo-cortical networks
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 11 2019
01 11 2019
Historique:
received:
07
06
2019
revised:
19
08
2019
accepted:
20
08
2019
pubmed:
25
8
2019
medline:
21
7
2020
entrez:
25
8
2019
Statut:
ppublish
Résumé
Non-competitive N-methyl-d-aspartate receptor antagonists mimic schizophrenia symptoms and produce immediate and persistent antidepressant effects. We investigated the effects of ketamine and phencyclidine (PCP) on thalamo-cortical network activity in awake, freely-moving male Wistar rats to gain new insight into the neuronal populations and brain circuits involved in the effects of NMDA-R antagonists. Single unit and local field potential (LFP) recordings were conducted in mediodorsal/centromedial thalamus and in medial prefrontal cortex (mPFC) using microelectrode arrays. Ketamine and PCP moderately increased the discharge rates of principal neurons in both areas while not attenuating the discharge of mPFC GABAergic interneurons. They also strongly affected LFP activity, reducing beta power and increasing that of gamma and high-frequency oscillation bands. These effects were short-lasting following the rapid pharmacokinetic profile of the drugs, and consequently were not present at 24 h after ketamine administration. The temporal profile of both drugs was remarkably different, with ketamine effects peaking earlier than PCP effects. Although this study is compatible with the glutamate hypothesis for fast-acting antidepressant action, it does not support a local disinhibition mechanism as the source for the increased pyramidal neuron activity in mPFC. The short-lasting increase in thalamo-cortical activity is likely associated with the rapid psychotomimetic action of both agents but could also be part of a cascade of events ultimately leading to the persistent antidepressant effects of ketamine. Changes in spectral contents of high-frequency bands by the drugs show potential as translational biomarkers for target engagement of NMDA-R modulators.
Identifiants
pubmed: 31445017
pii: S0028-3908(19)30304-1
doi: 10.1016/j.neuropharm.2019.107745
pii:
doi:
Substances chimiques
Excitatory Amino Acid Antagonists
0
Receptors, N-Methyl-D-Aspartate
0
Ketamine
690G0D6V8H
Phencyclidine
J1DOI7UV76
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
107745Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.